Text Size A A A

Taro Pharmaceuticals U.S.A. Issues Voluntary Nationwide Recall of Phenytoin Oral Suspension USP, 125 mg/5 mL Due to Possible Underdosing or Overdosing

Print Home » Taro Pharmaceuticals U.S.A. Issues Voluntary Nationwide Recall of Phenytoin Oral Suspension USP, 125 mg/5 mL Due to Possible Underdosing or Overdosing

Category:

Released Date: 
Thursday, February 20, 2020

Is HTML:

Url: 
https://taro.gcs-web.com/news-releases/news-release-details/taro-pharmaceuticals-usa-issues-voluntary-nationwide-recall